skip to main content

Prostate Cancer

Personal Growth After Cancer

Jeff Smith's prostate cancer diagnosis changed his perspective on life. After his treatment ended, he decided to leave behind all of those aspects of his life he didn’t love and start a new journey based on human connections.

Prostate Cancer and Hereditary Risk

Many of us are now aware that women with certain hereditary genetic mutations have an increased risk of breast cancer. What you might not know, though, is that some of those same genetic mutations -- and a handful of others -- are linked to aggressive prostate cancer in men.

Prostate Cancer Patient Documents His Treatment

Faced with 42 days of radiation therapy to treat his prostate cancer, Rodney Dan Marolf decided on the very first visit to make the daunting process a little more personal.

Immune response prognostic for prostate cancer survival, recurrence and response to radiation therapy

Date Visible: 
Monday, September 25, 2017 - 08:45
A new study finds that immune response in prostate cancer may be able to forecast how patients will respond to radiation therapy, as well as their likelihood of disease recurrence and survival outcomes.

Report: Black men with high-risk prostate cancer less likely to get aggressive treatment

Date Visible: 
Thursday, August 24, 2017 - 17:00

Reuters reports on a study published in European Urology that shows that black men in America with medium- and high-risk prostate tumors are less likely to get aggressive treatment than white men are.

Researchers propose new approach to identify genetic mutations in men with prostate cancer

Date Visible: 
Thursday, June 29, 2017 - 11:30

In a new study, researchers used a patient's own cancer history rather than family history to identify genetic mutations that might influence cancer treatment and risk for family members.

How precision medicine is improving prostate cancer detection

Date Visible: 
Tuesday, May 9, 2017 - 10:30
New, statistically derived guidelines are helping urologists across Michigan zero in on which prostate cancer patients to scan for spread of their disease.

A new approach to target an 'undruggable' prostate cancer driver

Date Visible: 
Thursday, March 23, 2017 - 12:00

When small-molecule inhibitors proved elusive, researchers developed a novel strategy: Using large molecule peptides to target a common prostate cancer driver. It may provide a path for developing new therapies against a challenging target.